Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Consolidated Balance Sheets

v3.19.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2019
Dec. 31, 2018
Current assets    
Cash and cash equivalents $ 367,843 $ 393,167
Accounts receivable, net 128,420 138,146
Inventories 131,731 123,524
Net investment in sales-type leases 2,193 2,658
Prepaid expenses 7,750 6,398
Other current assets 21,023 20,278
Total current assets 658,960 684,171
Non-current assets    
Net investment in sales-type leases - long-term 965 1,552
Property, plant and equipment, net 188,255 188,150
Goodwill 385,612 385,849
Other intangible assets, net 101,486 107,274
Operating lease right-of-use assets 27,408
Other non-current assets 22,456 21,258
Total non-current assets 726,182 704,083
Total assets 1,385,142 1,388,254
Current liabilities    
Accounts payable 43,033 45,855
Current portion of long-term debt 5,143
Accrued expenses and other current liabilities 29,831 39,115
Accrued compensation and related benefits 35,516 31,703
Deferred revenues 53,997 53,965
Operating lease liabilities - short term 9,439
Total current liabilities 171,816 175,781
Non-current liabilities    
Long-term debt 22,000
Deferred tax liabilities 1,391 1,662
Deferred revenues - long-term 17,307 18,422
Operating lease liabilities - long term 18,481
Other non-current liabilities 28,474 27,422
Total non-current liabilities 65,653 69,506
Total liabilities 237,469 245,287
Contingencies (see note 11)
Redeemable non-controlling interests 809 852
Equity    
Ordinary shares, NIS 0.01 nominal value, authorized 180,000 thousands shares; 54,048 thousands shares and 53,881 thousands shares issued and outstanding at March 31, 2019 and December 31, 2018, respectively 146 146
Additional paid-in capital 2,687,499 2,681,048
Accumulated other comprehensive loss (7,185) (7,753)
Accumulated deficit (1,533,596) (1,531,326)
Total equity 1,146,864 1,142,115
Total liabilities and equity $ 1,385,142 $ 1,388,254